Ketamine Therapy with a Substance Use History: Who Qualifies (2026)

If you have a history of alcohol, opioid, or other substance use and you're considering ketamine therapy, the honest summary upfront: candidacy depends much more on what's happening now than on what's in your history. Sustained recovery does not disqualify you. Active substance use often does, both for safety and because active substance use undermines ketamine's antidepressant effect. The line between those two is where the meaningful conversation lives.

This post is the version of the conversation we have at intake when there's a substance use history on the medical record. What changes based on the substance, the timeline, whether you're on medication-assisted treatment, and the realities of doing ketamine therapy alongside a 12-step recovery framework.

The short version

For most patients with substance use history:

• Active substance use (any class): pause ketamine candidacy until cessation and stabilization.
• Sustained recovery (typically 6+ months sober, active engagement with recovery supports): generally compatible with at-home ketamine, with the same candidacy as anyone else.
• Opioid use disorder on stable MAT (Suboxone, methadone, naltrexone): nuanced; usually a yes if MAT dose is stable, recovery is active, and we coordinate with the MAT prescriber.
• The 12-step / AA tension about whether ketamine "counts" as sobriety is real and worth addressing upfront with your sponsor before starting.
• Cannabis: daily heavy use is worth discussing; occasional or stable medical use is generally fine.
• Nicotine: not a disqualifier.
• Heavy recreational ketamine history: different category; needs a workup before therapeutic ketamine.

The detail behind each is below.

Why substance use history matters at intake

Three reasons that compound, not one:

Safety stacking. Many substances interact unpredictably with ketamine — alcohol stacks CNS depression and aspiration risk, benzodiazepines blunt ketamine's therapeutic mechanism, stimulants stack cardiovascular load, opioids stack respiratory depression. Active use during a session is a meaningful safety concern.

Treatment effectiveness. Ketamine's antidepressant effect depends on the neuroplasticity window it opens for the 24-72 hours after a session. Continued active substance use during that window (especially alcohol, benzos, cannabis) blunts or eliminates the effect. The treatment doesn't fail; the patient has spent the window on something that competes with it.

Addiction-as-disqualifier vs addiction-as-treatable-comorbidity. Patients with substance use disorder also often have depression, anxiety, PTSD, and chronic pain at meaningfully elevated rates. These are the conditions ketamine actually treats well. The right framing isn't "substance use history disqualifies you" — it's "your substance use needs to be stable enough that we can effectively treat the depression underneath it."

Alcohol: the most common conversation

Alcohol comes up at almost every intake. The breakdown:

• Active alcohol use disorder (AUD): a hard pause until cessation. Alcohol + ketamine + an unsupervised home setting is a stacked CNS depression risk that we don't accept regardless of how mild the AUD presentation looks.
• Heavy social drinking but no diagnosable AUD: discuss honestly. The 48-hour pre- and post-session alcohol abstention rule applies to everyone, but for heavy drinkers we want to understand whether they can actually hold to it.
• Moderate social drinking (1-2 drinks a few times a week): generally fine with the 48-hour abstention window around sessions.
• AUD in sustained recovery (6+ months sober, active engagement with recovery supports): generally a yes. The history doesn't disqualify; the active management of it is what we're verifying.
• Early sobriety from AUD (under 6 months): case-by-case. We don't categorically refuse but the conversation includes the patient's recovery provider where possible.

If you're stably in recovery from AUD and you're considering ketamine for depression that didn't go away when you got sober, this is one of the better candidacy scenarios — that pattern is common, and ketamine genuinely helps with the underlying mood condition that drove drinking in the first place. For the deeper alcohol-specific conversation, see ketamine and alcohol: the honest answer.

Opioid use disorder and MAT

A growing share of intakes involve patients stable on medication-assisted treatment for opioid use disorder. The honest breakdown by medication:

Buprenorphine / Suboxone

Stable on buprenorphine for 3+ months at a steady dose, engaged in recovery supports: generally a yes. Buprenorphine is a partial mu-opioid agonist, and the interaction with ketamine is well-tolerated at therapeutic doses. We coordinate with the buprenorphine prescriber so they know ketamine is in the picture. Naloxone (the second component of Suboxone) is inactive sublingually and isn't a factor for ketamine sessions.

Methadone

Stable on methadone at a steady dose, engaged with the clinic, attending appointments: generally a yes with closer attention to cardiovascular history. Methadone prolongs the QT interval; ketamine has its own transient cardiovascular effects. We get baseline EKG documentation, screen for QT-prolonging medications, and coordinate with the methadone clinic. Most stable methadone patients have done at-home ketamine without complication.

Naltrexone (oral or Vivitrol injection)

Naltrexone is a pure opioid antagonist used for AUD and OUD. Compatible with ketamine; no interaction issue. Continue on normal schedule. Naltrexone can be useful for patients with overlapping AUD/OUD history because it reduces alcohol reward as well.

Active untreated OUD or active opioid use

Hard pause. Active opioid use plus ketamine stacks respiratory depression and creates an unsafe profile, especially at home. The first step is engagement with OUD treatment (MAT or another evidence-based pathway), then re-evaluation for ketamine once treatment is stable.

Stimulant use disorder

Cocaine, methamphetamine, recreational amphetamine, and high-dose unprescribed stimulant use:

• Active stimulant use: hard pause. Stacks cardiovascular load with ketamine in ways we don't safely manage at home.
• Sustained recovery (6+ months, no use): generally a yes; the history doesn't disqualify if the current state is stable.
• Stimulant use disorder history alongside prescribed ADHD medication: this is a frequent overlap that needs honest discussion. If you have stimulant use disorder history and are now stable on prescribed Adderall/Vyvanse/methylphenidate under a psychiatrist's supervision, candidacy is the same as any patient on a prescribed stimulant. See ketamine for ADHD for the stimulant + ketamine timing protocol.

Benzodiazepine dependence

Benzodiazepines (alprazolam, clonazepam, lorazepam, diazepam) are a special case because they have both an active-use disorder risk AND a meaningful pharmacological interference with ketamine's mechanism.

• Active benzo use disorder (escalating dose, doctor shopping, withdrawal symptoms when off): needs addiction-medicine evaluation and stabilization before ketamine. Stopping benzos abruptly is medically dangerous; the right pathway is supervised taper.
• Stable prescribed benzodiazepine on a low-to-moderate dose with no escalation: continue as prescribed, but plan the dose timing around sessions. Benzos blunt ketamine's neuroplasticity effect; we typically ask patients to hold the morning dose on session days if they take one then.
• Prior benzo dependence, now off benzos: great candidate. The most consistent pattern is patients who escaped benzo dependence and now have residual anxiety; ketamine helps with the anxiety without the dependence risk.

For the timing details on benzos around ketamine sessions, see medication safety with ketamine.

Cannabis

Cannabis is the substance with the most ambiguity at intake because legal medical use, recreational use, and use disorder overlap:

• Occasional use (a few times a month, no disorder): generally fine. We ask for the 48-hour pre- and post-session abstention window for the same neuroplasticity reasons as alcohol.
• Daily moderate use (1-2 sessions a day, primarily evening): discuss. The candidacy is usually still yes but we want a conversation about whether daily use is masking the underlying depression the patient is trying to treat.
• Heavy daily use (multiple times throughout the day, has cannabis use disorder features): more like an AUD conversation — typically a pause, focused first on reducing cannabis use, then re-evaluating ketamine.
• Medical cannabis for chronic pain or PTSD: legitimate use; doesn't disqualify. Same 48-hour pre/post window applies.

For the day-of-session cannabis rules and why the 48-hour window matters mechanistically, see medication safety with ketamine.

The recreational ketamine history question

This deserves its own paragraph. If you have a history of heavy recreational ketamine use (multiple grams per week for months to years), there are two things to think about:

1. Possible biliary tract injury from chronic heavy use. Heavy recreational ketamine is associated with a syndrome called "ketamine-induced cholangiopathy." If you have a history matching that pattern, your prescribing physician will want recent imaging and labs (LFT panel, possibly an MRCP) before adding therapeutic ketamine to the picture.
2. Distinct dose-response and tolerance considerations. Patients with heavy recreational history sometimes have a higher tolerance, which affects therapeutic dosing strategy. This is a workup-and-adjust scenario, not a categorical disqualifier.

Light or infrequent past recreational ketamine use (a few times years ago) doesn't trigger any of the above and isn't a candidacy factor.

The 12-step / AA question

This comes up at almost every intake with patients in 12-step recovery. The honest framing:

Some 12-step communities don't consider medication-assisted treatment for mood disorders to be a violation of sobriety; some do. The AA literature itself is silent on ketamine specifically. Whether your home group, your sponsor, and your support community accept ketamine as compatible with your sobriety is something you'll know better than your prescribing physician.

What I can say from the clinical side:

• Ketamine, used as a physician-prescribed medication for depression, is medication treatment of a separate condition (depression/anxiety/PTSD) — the same logic that supports SSRIs, mood stabilizers, and other psychiatric medications in recovery.
• The dissociative experience of a session is genuinely different from a recreational alcohol or drug experience; many patients in recovery describe it as more like a meditation or therapy session than like a "high."
• Patients who tell their sponsor and recovery community in advance, frame it as treatment for a separate condition, and continue active engagement with their recovery program generally do well integrating ketamine into a recovery framework.
• Patients who keep ketamine secret from their recovery community tend to do less well — the secrecy itself works against recovery principles.

Doc tells patients honestly: this is a conversation to have with your sponsor first. Not something to hide.

What "stable" actually means

When I say "sustained recovery" the working definitions are:

• AUD or non-opioid SUD: 6+ months without active use, engaged with a recovery framework (12-step, SMART, individual therapy, IOP graduation, etc.), self-reported abstinence verified by recovery provider when possible.
• OUD on MAT: 3+ months on a stable MAT dose (no recent up-titrations), attending appointments, no positive urine drug screens for non-MAT substances.
• Earlier than these thresholds: case-by-case. We don't categorically refuse, but the conversation is more involved and we coordinate with the patient's addiction provider before starting.

These aren't bright lines so much as working defaults. Patients earlier in recovery with strong support and a compelling depression case can be candidates; patients later in recovery without active engagement may need more conversation.

When at-home ketamine is not the right fit

Real situations where we either defer or shift to in-clinic care:

• Active untreated substance use disorder of any class
• Recent overdose (within the last 6 months) — needs addiction-medicine stabilization first
• Polysubstance use disorder with multiple active concerns
• No engagement with a recovery framework in a patient with recent active SUD
• Severe AUD with active liver complications — overlap with the liver disease candidacy framework
• History of injecting drug use within the last 12 months — not because of any direct ketamine interaction but because the patient's general medical state and bloodborne-disease screening needs more attention than a typical at-home intake

These aren't moralistic exclusions — they're situations where the at-home model can't safely deliver what the patient actually needs. The right move in each case is engagement with the right level of care first, then potentially ketamine later.

Frequently Asked Questions

Can I do ketamine if I'm in AA or 12-step recovery?

Clinically, yes — physician-prescribed ketamine for depression is medication treatment of a separate condition, the same framework that supports SSRIs and other psychiatric medications in recovery. Socially, the answer depends on your sponsor and home group's stance, which varies. The right step is to have the conversation with your sponsor before starting rather than after. Patients who frame ketamine as treatment for a separate condition and stay engaged with their recovery program generally integrate it well.

How long do I need to be sober before doing ketamine therapy?

Working defaults: 6 months of sustained recovery for AUD or non-opioid SUD with active engagement in a recovery framework, 3 months on a stable MAT dose for OUD. Earlier than these thresholds isn't a categorical no; it's a more involved conversation and usually coordinates with your addiction provider. The point of the timeline isn't punitive — it's that earlier active recovery work needs the patient's full bandwidth without adding a new variable.

Can you do ketamine on Suboxone or buprenorphine?

Yes, in most cases. Stable buprenorphine for 3+ months at a steady dose, with active engagement in recovery supports, is generally compatible with at-home ketamine therapy. Buprenorphine is a partial mu-opioid agonist with a well-tolerated interaction profile at therapeutic ketamine doses. We coordinate with your buprenorphine prescriber so they know ketamine is in the picture.

Can you do ketamine on methadone?

Yes, with extra attention to cardiovascular history. Stable methadone patients have done at-home ketamine without complication; we get baseline EKG documentation (methadone prolongs QT interval, ketamine has transient cardiovascular effects) and coordinate with the methadone clinic. The patient needs to be stable on dose and attending clinic appointments.

What about naltrexone or Vivitrol?

Compatible with ketamine; no interaction issue. Continue naltrexone on normal schedule. Naltrexone is useful for overlapping AUD/OUD history because it blocks both alcohol and opioid reward; the combination with ketamine doesn't change anything about either medication's mechanism.

Will ketamine itself be addictive for me?

In supervised therapeutic dosing — sublingual sessions spaced weekly or every other week with a peer supervisor present and a physician-managed protocol — the dependency potential is very low. The structural features that drive recreational ketamine dependence (frequent self-administration, escalating doses, compulsive use) are designed out of the at-home therapeutic protocol. Patients with substance use history sometimes have heightened concern about this; the honest answer is the protocol is built specifically to prevent the pattern.

Can ketamine treat alcohol use disorder?

Emerging research supports ketamine as a useful adjunct in AUD treatment, particularly the early-stage trials that combined ketamine sessions with motivational enhancement therapy or CBT. It's not a standalone AUD treatment and not currently part of standard AUD care. At DK we don't position ketamine as a primary AUD treatment; we treat the depression, anxiety, and PTSD that often co-occur with AUD in patients who've already stabilized the alcohol side through other means.

What about cannabis use?

Occasional cannabis use (a few times a month) doesn't disqualify. Daily moderate use is worth discussing — the question is usually whether daily use is masking depression we're trying to treat. Heavy daily use with cannabis use disorder features is more like an AUD conversation: we usually pause ketamine until cannabis use is reduced, then re-evaluate. The standard 48-hour pre- and post-session abstention window applies regardless.

Will my prescribing physician test me for substances?

We don't routinely run urine drug screens at intake; intake is honest self-report. For patients with active OUD on MAT we may ask for documentation of the MAT prescriber's monitoring screens. For patients in early recovery from non-opioid SUD we may ask for the recovery provider's confirmation of abstinence. The intake is collaborative, not adversarial.

Can I do ketamine if I have a recreational ketamine history?

Light or infrequent past recreational use (a few times years ago) doesn't affect candidacy. Heavy chronic recreational use (multiple grams per week for months to years) needs a workup first — recent liver labs and possibly imaging to rule out biliary tract injury, plus a dose-titration plan that accounts for possible tolerance. We don't categorically refuse but we want the picture clear before starting.

Ready to See Where You Stand?

If you have a substance use history and want to know whether at-home ketamine therapy fits your specific situation, I'm here to take a look. Dr. Ben Soffer is a board-certified physician with internal medicine training; coordinating care with addiction providers, MAT prescribers, and recovery frameworks is part of how this practice operates. Every intake includes an honest conversation about your substance history and current state.

For specific substance details: ketamine and alcohol. For the comorbid medical picture, see ketamine therapy with liver disease, hypertension, and diabetes. For the broader candidacy framework, see 12 ketamine contraindications. For medication interactions including benzodiazepines and the cannabis day-of-session rules, see medication safety with ketamine.

The five-minute eligibility check is the starting point. If your situation needs more conversation, we'll arrange a direct consultation.